University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Maxwell V. Meng, MD

Maxwell V. Meng, MD

Associate Professor, Department of Urology, UCSF

Cancer Center Program Memberships

Prostate Cancer

Education

A, 1991, Biochemical Sciences, Harvard College, Cambridge, MA
MD, 1995, Medicine, Johns Hopkins School of Medicine, Baltimore, MD
General surgery & urology, UCSF, 1995-2001
Laparoscopic fellowship, UCSF, 2001-2002
Oncology fellowship, UCSF, 2002-2003


Professional Experience

  • 2001-2003
    Clinical Instructor, Dept. of Urology, UCSF
  • 2001-present
    Attending Surgeon, San Francisco Veterans Hospital
  • 2001-present
    Attending Surgeon, San Francisco General Hospital
  • 2003-2007
    Assistant Professor in Residence, Dept. of Urology, UCSF
  • 2007-present
    Associate Professor in Residence, Dept. of Urology, UCSF

Honors & Awards

  • 1987
    Westinghouse Science Talent Search, 7th Place
  • 1991
    Magna cum laude, Harvard College
  • 1995
    Alpha Omega Alpha, Johns Hopkins
  • 1999
    Third Prize, Northern California Urology Residents Seminar
  • 1999
    Pfizer Scholar in Urology
  • 2001
    Joseph F. McCarthy Essay Contest, 3rd Place, Western Section AUA
  • 2002
    Prostate Cancer Research Fellow
  • 2004
    William R. Smart Distinguished Teaching Award (selected by residents)
  • 2005
    Excellence in Direct Teaching, Academy of Medical Educators, UCSF
  • 2006
    Ambrose/Reed Socioeconomic Prize Essay (AUA)
  • 2006
    AUA leadership Program (1 of 16 selected nationally biennially)
  • 2006
    Miley B. Wesson Essay Contest, 2nd Place, AUA

Selected Publications

  1. Hussein AA, Sexton KJ, May PR, Meng MV, Hosseini A, Eun DD, Daneshmand S, Bochner BH, Peabody JO, Abaza R, Skinner EC, Hautmann RE, Guru KA. Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men. Surg Endosc. 2018 Apr 13.
    View on PubMed
  2. Sanford T, Meng MV, Railkar R, Agarwal PK, Porten SP. Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma. Clin Epigenetics. 2018; 10:19.
    View on PubMed
  3. Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy. Cancer. 2017 Dec 01; 123(23):4574-4582.
    View on PubMed
  4. Meng M. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 2):6371S-6376S. Urol Oncol. 2017 May; 35(5):313-314.
    View on PubMed
  5. Meng M. Frozen section during partial nephrectomy: Does it predict positive margins? Gordetsky J, Gorin MA, Canner J, Ball MW, Pierorazio PM, Allaf ME, Epstein JI. BJU Int. 2015 Dec; 116(6):868-72. [Epub 2015 Mar 23]. doi: 10.1111/bju.13011. Urol Oncol. 2017 May; 35(5):312-313.
    View on PubMed
  6. Meng M. Laparoscopic cryoablation for renal cell carcinoma: 100-Month oncologic outcomes. Caputo PA, Ramirez D, Zargar H, Akca O, Andrade HS, O'Malley C, Remer EM, Kaouk JH. J Urol. 2015 Oct;194(4):892-896. [Epub 2015 April 23]. doi: 10.1016/j.juro.2015.03.128. Urol Oncol. 2017 May; 35(5):311-312.
    View on PubMed
  7. Meng M. Urologic Oncologic SurveyRobotic level III inferior vena cava tumor thrombectomy: Initial series. Gill IS, Metcalfe C, Abreu A, Duddalwar V, Chopra S, Cunningham M, Thangathurai D, Ukimura O, Satkunasivam R, Hung A, Papalia R, Aron M, Desai M, Gallucci M. J Urol. 2015 Oct;194(4):929-938. [Epub 2015 Apr 6]. doi: 10.1016/j.juro.2015.03.119. Urol Oncol. 2017 May; 35(5):311.
    View on PubMed
  8. Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes. PLoS One. 2016; 11(10):e0164558.
    View on PubMed
  9. Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR. A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy. J Urol. 2017 Feb; 197(2):369-375.
    View on PubMed
  10. Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR. Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy. Clin Genitourin Cancer. 2017 02; 15(1):93-99.
    View on PubMed
  11. Leapman MS, Clark CJ, Meng MV, Boughey JC. Diet and lifestyle can influence prostate cancer outcomes. Bull Am Coll Surg. 2016 07; 101(7):50-2.
    View on PubMed
  12. Meng MV. Editorial Comment. Urology. 2016 05; 91:232-3.
    View on PubMed
  13. Odisho AY, Rabban JT, Meng MV. Development of CNS-type Primitive Neuroectodermal Tumor in Metastatic Testicular Mixed Germ Cell Tumor. Urol Case Rep. 2016 May; 6:7-8.
    View on PubMed
  14. Tang Q, Song Y, Li X, Meng M, Zhang Q, Wang J, He Z, Zhou L. Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level. Biomed Res Int. 2015; 2015:163423.
    View on PubMed
  15. Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, Nicolas MM, Sanda MG, Simko J, So A, Tretiakova MS, Troyer DA, True LD, Vakar-Lopez F, Virgin J, Wagner AA, Wei JT, Zheng Y, Nelson PS, Lin DW. Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort. J Urol. 2016 Feb; 195(2):313-20.
    View on PubMed
  16. Sanford T, Porten S, Meng MV. Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison. PLoS One. 2015; 10(8):e0137141.
    View on PubMed
  17. Meng MV. Editorial Comment. J Urol. 2015 Aug; 194(2):309.
    View on PubMed
  18. Meng M. Editorial comment for Sharma et al. J Endourol. 2015 May; 29(5):567-8.
    View on PubMed
  19. Rabow MW, Benner C, Shepard N, Meng MV. Concurrent urologic and palliative care after cystectomy for treatment of muscle-invasive bladder cancer. Urol Oncol. 2015 Jun; 33(6):267.e23-9.
    View on PubMed
  20. Tran G, Ramaswamy K, Chi T, Meng M, Freise C, Stoller ML. Laparoscopic Nephrectomy with Autotransplantation: Safety, Efficacy and Long-Term Durability. J Urol. 2015 Sep; 194(3):738-743.
    View on PubMed

Go to UCSF Profiles, powered by CTSI